Home / Recalls / Apollo Care, LLC / D-0747-2026

D-0747-2026 Class II Ongoing

Recalled by Apollo Care, LLC — Columbia, MO

FDA drug recall D-0747-2026 was initiated by Apollo Care, LLC on Jul 29, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material The recall status is ongoing. Affected quantity: 56,918 vials.

Recall Details

Product Type: Drugs
Report Date: Aug 19, 2026
Initiation Date: Jul 29, 2026
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 56,918 vials.

Product Description

SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05

Reason for Recall

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Distribution Pattern

Nationwide within the U.S

Code Information

Lot: AC-017108, Exp. 11/17/2026; AC-017110, Exp. 11/20/2026; AC-017112, Exp. 11/21/2026; AC-017142, AC-017144, Exp. 12/10/2026; AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, AC-017225, Exp. 12/31/2026

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0747-2026
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Apollo Care, LLC

D-0753-2026 Class II — SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose… (Jul 29, 2026)
D-0750-2026 Class II — SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For… (Jul 29, 2026)
D-0748-2026 Class II — SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For… (Jul 29, 2026)
D-0752-2026 Class II — SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For… (Jul 29, 2026)
D-0754-2026 Class II — SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial… (Jul 29, 2026)
D-0757-2026 Class II — SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial… (Jul 29, 2026)
D-0755-2026 Class II — SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose… (Jul 29, 2026)
D-0756-2026 Class II — SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial… (Jul 29, 2026)
D-0751-2026 Class II — SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For… (Jul 29, 2026)
D-0749-2026 Class II — SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For… (Jul 29, 2026)